Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

13.79 

0.11 0.8%

as of Nov 11 '19

52 Week Range:

7.59 34.14


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E mediated cow's milk protein allergy (CMPA) and milk-induced eosinophilic esophagitis; Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include vaccine for respiratory syncytial virus, as well as treatments for Crohn's disease, hemophilia A, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of CMPA in infants and toddlers. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 2.92
2.21
1.65
4.36
11.79
7.67
6.80
growth rate -24.3% -25.3% 164.2% 170.4% -34.9% -11.3%
Earnings BIT -7.24
-13.01
-19.95
-24.65
-45.56
-116.04
-145.00
-166.23
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Avg.PE -4.50
-4.50
-4.50
-4.50
-7.31
-7.31
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
ROA -46.06
-44.34
-43.28
-27.98
-19.06
-36.31
-63.48
-95.02
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ROE -61.86
-51.15
-48.53
-30.82
-20.42
-40.55
-79.24
-132.22
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ROIC -57.97
-51.10
-48.57
-30.53
-20.40
-40.40
-76.00
-128.93
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cur. Ratio 4.41
13.12
10.35
21.90
20.90
9.38
4.37
3.34
growth rate 197.5% -21.1% 111.6% -4.6% -55.1% -53.4% -23.6%
Quick Ratio 3.52
13.05
10.27
21.70
20.79
9.29
4.31
3.21
growth rate 270.7% -21.3% 111.3% -4.2% -55.3% -53.6% -25.5%
Leverage 1.34
1.09
1.14
1.09
1.07
1.18
1.37
1.42
growth rate -18.7% 4.6% -4.4% -1.8% 10.3% 16.1% 3.7%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 2.00
2.00
3.00
4.09
5.92
9.66
12.98
16.93
16.87
growth rate 0.0% 50.0% 36.3% 44.8% 63.2% 34.3% 30.5% -0.4%
Acct.Payable 1.00
2.00
1.00
1.50
1.88
10.03
13.72
16.94
28.57
growth rate 100.0% -50.0% 49.7% 25.3% 435.2% 36.7% 23.5% 68.6%
Cur.Assets 11.00
14.00
42.00
43.82
121.57
334.89
272.18
156.87
145.47
growth rate 27.3% 200.0% 4.3% 177.5% 175.5% -18.7% -42.4% -7.3%
Total Assets 12.00
16.00
43.00
46.24
125.42
343.28
287.50
177.81
171.75
growth rate 33.3% 168.8% 7.5% 171.3% 173.7% -16.3% -38.2% -3.4%
Cash 9.00
12.00
38.00
39.40
114.58
323.38
256.47
137.88
122.77
growth rate 33.3% 216.7% 3.7% 190.8% 182.2% -20.7% -46.2% -11.0%
Inventory 0.01
0.12
1.57
growth rate 1,671.4% 88.5%
Cur.Liabilities 2.00
3.00
3.00
4.23
5.55
16.02
29.00
35.93
43.54
growth rate 50.0% 0.0% 41.1% 31.1% 188.6% 81.0% 23.9% 21.2%
Liabilities 3.00
4.00
4.00
5.84
9.97
21.20
44.65
47.88
50.46
growth rate 33.3% 0.0% 46.0% 70.7% 112.7% 110.6% 7.2% 5.4%
LT Debt 1.00
1.00
0.40
1.32
3.89
4.69
4.05
1.83
1.28
growth rate 0.0% -60.0% 229.3% 195.2% 20.7% -13.7% -54.9% -30.0%
Equity 11.70
39.20
40.40
115.45
322.08
242.85
129.92
121.29
growth rate 235.0% 3.1% 185.8% 179.0% -24.6% -46.5% -6.7%
Common Shares 13.00
12.00
14.00
16.00
22.00
24.00
25.00
29.00
growth rate -7.7% 16.7% 14.3% 37.5% 9.1% 4.2% 16.0%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 1.00
0.30
1.09
0.94
4.36
7.99
7.25
4.71
growth rate -70.0% 263.3% -13.7% 363.3% 83.3% -9.3% -35.0%
Cash From OA -13.25
-20.56
-26.76
-59.54
-114.31
-136.62
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
FCF per Share -0.81
-0.81
-1.22
-1.30
-2.25
-2.75
-4.06
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sale Purchase of Stock 15.36
105.52
285.55
1.44
0.62
growth rate 587.0% 170.6% -99.5% -56.7%
FCF -7.00
-11.00
-14.00
-22.00
-31.00
-68.00
-122.00
-141.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 2.00
2.00
3.00
3.83
4.76
6.17
7.53
9.60
11.19
growth rate 0.0% 50.0% 27.5% 24.5% 29.5% 22.1% 27.5% 16.5%
Op.Income -5.00
-7.00
-13.00
-19.95
-24.65
-45.56
-116.04
-145.00
-166.23
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
IBT -7.20
-12.90
-19.31
-24.01
-44.67
-114.53
-147.69
-166.06
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Net Income -5.00
-7.00
-13.00
-19.31
-24.01
-44.67
-114.53
-147.69
-166.08
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS -0.54
-1.05
-1.42
-1.49
-2.08
-4.68
-5.97
-5.74
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Gross Profit 2.00
2.00
3.00
3.72
4.60
5.96
7.53
9.60
11.19
growth rate 0.0% 50.0% 24.1% 23.6% 29.5% 26.3% 27.5% 16.5%
R&D 6.70
11.50
17.37
20.87
33.06
76.93
103.21
104.47
growth rate 71.6% 51.0% 20.2% 58.5% 132.7% 34.2% 1.2%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT -36.76
-46.35
-46.35
-39.66
-39.66
growth rate 0.0% 0.0% 0.0% 0.0%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 25.20
16.87
16.87
22.71
22.71
growth rate -33.1% 0.0% 34.6% 0.0%
Acct.Payable 21.60
28.57
28.57
22.31
22.31
growth rate 32.3% 0.0% -21.9% 0.0%
Cur.Assets 230.28
145.47
145.47
137.53
137.53
growth rate -36.8% 0.0% -5.5% 0.0%
Total Assets 250.27
171.75
171.75
186.66
186.66
growth rate -31.4% 0.0% 8.7% 0.0%
Cash 202.25
122.77
122.77
107.27
107.27
growth rate -39.3% 0.0% -12.6% 0.0%
Inventory 1.57
1.57
2.08
2.08
growth rate 0.0% 33.0% 0.0%
Cur.Liabilities 34.92
43.54
43.54
45.80
45.80
growth rate 24.7% 0.0% 5.2% 0.0%
Liabilities 45.35
50.46
50.46
70.34
70.34
growth rate 11.3% 0.0% 39.4% 0.0%
LT Debt 1.55
1.28
1.28
1.00
1.00
growth rate -17.6% 0.0% -21.5% 0.0%
Equity 204.92
121.29
121.29
116.33
116.33
growth rate -40.8% 0.0% -4.1% 0.0%
Common Shares 3.00
3.02
3.02
3.62
3.62
growth rate 0.5% 0.0% 19.9% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 0.25
2.11
2.11
1.06
1.06
growth rate 745.8% 0.0% -49.7% 0.0%
Cash From OA -32.59
-35.73
-35.73
-38.59
-38.59
growth rate 0.0% 0.0% 0.0% 0.0%
Sale Purchase of Stock
growth rate
FCF -32.83
-37.83
-37.83
-39.64
-39.64
growth rate 0.0% 0.0% 0.0% 0.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 2.92
2.67
2.67
2.99
2.99
growth rate -8.6% 0.0% 11.8% 0.0%
Op.Income -36.76
-46.35
-46.35
-39.66
-39.66
growth rate 0.0% 0.0% 0.0% 0.0%
IBT -36.04
-46.99
-46.99
-39.90
-39.90
growth rate 0.0% 0.0% 0.0% 0.0%
Net Income -36.04
-47.00
-47.00
-39.91
-39.91
growth rate 0.0% 0.0% 0.0% 0.0%
Gross Profit 2.92
2.67
2.67
2.99
2.99
growth rate -8.6% 0.0% 11.8% 0.0%
R&D 24.49
27.74
27.74
25.95
25.95
growth rate 13.3% 0.0% -6.5% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (3.86)

YOY Growth Grade:

F (2.80)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE -7.31 -2.50 -3.31
EPS / Growth -5.51 -21.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 3.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 2.1% 2.1%
Future PE 0.01 0.01 1.41
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.